vTv Therapeutics Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
vTv Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2015 to Q2 2024.
  • vTv Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $859K, a 115% increase year-over-year.
  • vTv Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.92M, a 39.7% increase year-over-year.
  • vTv Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.58M, a 24.1% increase from 2022.
  • vTv Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.27M, a 46% decline from 2021.
  • vTv Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.36M, a 133% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.92M $859K +$460K +115% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.46M $220K -$123K -35.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.58M $403K +$112K +38.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $1.47M $433K +$95K +28.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.37M $399K +$232K +139% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.14M $343K -$133K -27.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.27M $291K -$703K -70.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.98M $338K -$136K -28.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.11M $167K -$285K -63.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $2.4M $476K +$40K +9.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.36M $994K +$722K +265% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $1.63M $474K +$303K +177% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.33M $452K +$266K +143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.07M $436K +$56K +14.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.01M $272K -$151K -35.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $1.16M $171K -$242K -58.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.4M $186K -$215K -53.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.62M $380K +$99K +35.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $1.52M $423K +$92K +27.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-29
Q3 2019 $1.43M $413K -$166K -28.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.59M $401K -$402K -50.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $1.99M $281K -$682K -70.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.68M $331K -$715K -68.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $3.39M $579K -$380K -39.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $3.77M $803K -$156K -16.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $3.93M $963K +$282K +41.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $3.65M $1.05M +$392K +59.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $3.25M $959K +$278K +40.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.98M $959K +$260K +37.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $2.72M $681K +$74K +12.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $2.64M $654K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $681K +$377K +124% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $699K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $607K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q3 2015 $304K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.